Collectively, our data indicate that CHAC2 is required for stemness in LMP1-expressing cells, and that targeting CHAC2 and LSD1 can be effective approaches for suppressing the stemness of EBV-positive B cell lymphoma cells. Here, PDLIM7 is linked to B-cell non-Hodgkin lymphoma.